Pulmonary Manifestations of Sjögren's Syndrome

George Stojan; Alan N. Baer; Sonye K. Danoff

doi:10.1007/s11882-013-0357-9

Pulmonary Manifestations of Sjögren's Syndrome

George Stojan, Alan N. Baer, Sonye K. Danoff

School of Medicine

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

Sjögren's syndrome (SS) is primarily defined by its impact on the oral and ocular system resulting in xerostomia and xerophthalmia. However, SS can also manifest throughout the respiratory system. Subclinical pulmonary involvement is common. Clinically significant involvement can result in a 4-fold increased risk of death. Thus, recognizing the many potential presentations of SS in the lung is critical in caring for patients with SS. Additionally, SS should be included in the differential diagnosis of a number of forms of interstitial lung disease.

Original language	English (US)
Pages (from-to)	354-360
Number of pages	7
Journal	Current allergy and asthma reports
Volume	13
Issue number	4
DOIs	https://doi.org/10.1007/s11882-013-0357-9
State	Published - Aug 2013

Keywords

Bamboo node
Bronchus-associated lymphoid tissue
Chronic obstructive pulmonary disease
Cough
Cystic lung disease
Epistaxis
Follicular bronchiolitis
Follicular bronchitis
Hoarseness
Lymphocytic interstitial pneumonia
Nasal septal perforation
Non-specific interstitial pneumonia
Pulmonary amyloidosis
Pulmonary hypertension
Sjogren's syndrome
Xerotrachea

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pulmonary and Respiratory Medicine

Access to Document

10.1007/s11882-013-0357-9

Cite this

@article{808651f3e97f484782105ffb8bfd3782,

title = "Pulmonary Manifestations of Sj{\"o}gren's Syndrome",

abstract = "Sj{\"o}gren's syndrome (SS) is primarily defined by its impact on the oral and ocular system resulting in xerostomia and xerophthalmia. However, SS can also manifest throughout the respiratory system. Subclinical pulmonary involvement is common. Clinically significant involvement can result in a 4-fold increased risk of death. Thus, recognizing the many potential presentations of SS in the lung is critical in caring for patients with SS. Additionally, SS should be included in the differential diagnosis of a number of forms of interstitial lung disease.",

keywords = "Bamboo node, Bronchus-associated lymphoid tissue, Chronic obstructive pulmonary disease, Cough, Cystic lung disease, Epistaxis, Follicular bronchiolitis, Follicular bronchitis, Hoarseness, Lymphocytic interstitial pneumonia, Nasal septal perforation, Non-specific interstitial pneumonia, Pulmonary amyloidosis, Pulmonary hypertension, Sjogren's syndrome, Xerotrachea",

author = "George Stojan and Baer, {Alan N.} and Danoff, {Sonye K.}",

note = "Funding Information: Acknowledgments This work was supported by T32 grant to GS and Fisher Foundation Fund for PF to SD.",

year = "2013",

month = aug,

doi = "10.1007/s11882-013-0357-9",

language = "English (US)",

volume = "13",

pages = "354--360",

journal = "Current allergy and asthma reports",

issn = "1529-7322",

publisher = "Current Medicine Group",

number = "4",

}

TY - JOUR

T1 - Pulmonary Manifestations of Sjögren's Syndrome

AU - Stojan, George

AU - Baer, Alan N.

AU - Danoff, Sonye K.

N1 - Funding Information: Acknowledgments This work was supported by T32 grant to GS and Fisher Foundation Fund for PF to SD.

PY - 2013/8

Y1 - 2013/8

N2 - Sjögren's syndrome (SS) is primarily defined by its impact on the oral and ocular system resulting in xerostomia and xerophthalmia. However, SS can also manifest throughout the respiratory system. Subclinical pulmonary involvement is common. Clinically significant involvement can result in a 4-fold increased risk of death. Thus, recognizing the many potential presentations of SS in the lung is critical in caring for patients with SS. Additionally, SS should be included in the differential diagnosis of a number of forms of interstitial lung disease.

AB - Sjögren's syndrome (SS) is primarily defined by its impact on the oral and ocular system resulting in xerostomia and xerophthalmia. However, SS can also manifest throughout the respiratory system. Subclinical pulmonary involvement is common. Clinically significant involvement can result in a 4-fold increased risk of death. Thus, recognizing the many potential presentations of SS in the lung is critical in caring for patients with SS. Additionally, SS should be included in the differential diagnosis of a number of forms of interstitial lung disease.

KW - Bamboo node

KW - Bronchus-associated lymphoid tissue

KW - Chronic obstructive pulmonary disease

KW - Cough

KW - Cystic lung disease

KW - Epistaxis

KW - Follicular bronchiolitis

KW - Follicular bronchitis

KW - Hoarseness

KW - Lymphocytic interstitial pneumonia

KW - Nasal septal perforation

KW - Non-specific interstitial pneumonia

KW - Pulmonary amyloidosis

KW - Pulmonary hypertension

KW - Sjogren's syndrome

KW - Xerotrachea

UR - http://www.scopus.com/inward/record.url?scp=84881131956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881131956&partnerID=8YFLogxK

U2 - 10.1007/s11882-013-0357-9

DO - 10.1007/s11882-013-0357-9

M3 - Article

C2 - 23797265

AN - SCOPUS:84881131956

SN - 1529-7322

VL - 13

SP - 354

EP - 360

JO - Current allergy and asthma reports

JF - Current allergy and asthma reports

IS - 4

ER -

Pulmonary Manifestations of Sjögren's Syndrome

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this